April 24th 2024
FDA recalls, allergy alerts, e coli & salmonella outbreaks, and more.
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Burst CME: Incorporating the Latest Updates in IBS Treatment into Your Practice
View More
Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Cancer Summaries and Commentaries™: Clinical Updates in RCC from Chicago
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Working Group: Streamlining the Pathway from Diagnosis to Treatment in Inflammatory Bowel Disease
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Doctors Discover New Treatment for “Superbug” C. difficile
September 22nd 2016As so-called “superbug” bacteria continue to develop new ways of resisting antibiotics, scientists are on the search for new and alternative treatments. Promising news from a recent study is now showing that we may be able to battle the most virulent strains of the Clostridium difficile bacteria with a class of drugs already on the market.
Read More
Rutgers & Columbia Researchers Discover New Strain of Multi-drug Resistant E. coli
September 21st 2016A team of scientists from Rutgers University and Columbia University recently discovered a new strain of Escherichia coli (E. coli) believed to be the first in the United States with resistance to two kinds of antibiotics considered to be last resort weapons to prevent dangerous infections.
Read More
Mycophenolic Acid Treatment May Be Useful to Treat Rotavirus Infection in Transplant Patients
September 16th 2016Based on 2D and 3D in vitro models, treatment with mycophenolic acid confers very high levels of drug resistant rotavirus viral replication suppression and may therefore be a useful immunosuppressive agent for preventing rotavirus infection in transplantation patients.
Read More
New Hand, Foot, and Mouth Disease Outbreaks at New Jersey and Florida Schools
September 16th 2016With schools and colleges back in session, so too are contagious illnesses such as hand, foot, and mouth disease, which has recently broken out in two New Jersey high schools and a Florida university.
Read More
E. coli with Antibiotic-resistant mcr-1 Gene Found in Connecticut Child
September 13th 2016The CDC recently announced that their investigators have identified a strain of Escherichia coli with the colistin-resistance gene mcr-1 in a Connecticut child, in what is now the fourth patient in the United States to test positive for an isolate with mcr-1.
Read More
FDA Grants QIDP Designation to MGB-BP-3 to Treat Clostridium difficile-associated Diarrhea
September 12th 2016The FDA has granted biopharmaceutical company, MGB Biopharma’s lead candidate, MGB-BP-3, Qualified Infectious Disease Product (QIDP) designation for the treatment of Clostridium difficile-associated Diarrhea.
Read More
Study Finds Food and Healthcare Workers More Susceptible to Norovirus
August 26th 2016Individuals who handle foods in the course of their work, as well as those working in healthcare settings, have a higher risk for infection with highly contagious, gastroenteritis-inducing noroviruses when an outbreak occurs where they work.
Read More
New Genetic Research Holds Promise for C. Difficile Treatment
August 25th 2016In the battle against drug-resistant pathogens, genetic research holds promising answers to our toughest threats. A new study shows that the best tool for treating Clostridium difficile infections could be within the genome of the bacteria itself.
Read More
Probiotics Could Offer Important Line of Defense Against Drug-resistant Bacteria
August 23rd 2016As the rise of antibiotic-resistant bacteria leads to higher rates of life-threatening infections from pathogens such Clostridium difficile and methicillin-resistant Staphylococcus aureus (MRSA), researchers are increasingly looking to probiotic treatment as an important part of fighting infections.
Read More
Are Phage-based Treatments the Solution for C. difficile Infection?
July 4th 2016A new bacteriophage (phage) treatment-based approach to fighting Clostridium difficile (C. difficile) colonization and infection may one day provide for effective treatment against this potentially lethal disease.
Read More
Studies Highlight Worldwide Economic Burden of Norovirus Gastroenteritis
June 6th 2016Each year, norovirus infection is responsible for an estimated 684 million episodes of diarrhea and 212,000 deaths worldwide, and results in approximately $4.2 billion in healthcare costs and $60.3 billion in societal costs, a new report has highlighted.
Read More
Knowledge of Cholera Lacking in Regions Where the Disease is Most Prevalent
April 1st 2016The findings of a recent study suggest that knowledge of cholera and its symptoms is sorely lacking among female caretakers in the Indian sub-continent—despite the fact that the disease has been present in the region for centuries.
Read More